Ruxolitinib for Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome: Two Pediatric Cases and Literature Review

• by Liu, Honglin , Zhang, Wei

• May 5, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

• by Kathryn Wighton

• February 18, 2026

• 3 min

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses

• by Salima Shebbo, Doaa Elsayed Mahmoud, Nooralhuda Alateyah, Seyedeh H. Hosseini, Amal Al-Haidose, Salam A. Ramirez, Asad Zeidan, Atiyeh M. Abdallah

• May 5, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min